How digital health companies are capitalizing on the GLP-1 boom
Joining the market for GLP-1s is a massive opportunity, and digital health companies from Ro to WeightWatchers are battling for market share.
Stay updated with breaking news from Ro Body Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Joining the market for GLP-1s is a massive opportunity, and digital health companies from Ro to WeightWatchers are battling for market share.
Saman Rahmanian, Chief Product Officer and Co-founder of Ro, leverages behavioral design in healthcare by decreasing friction and promoting autonomy for patients.
What real women wish people knew about life on Ozempic and other medications.
Ro's new weight-loss program could be its fastest-growing business ever. But response delays, drug shortages, and insurance snags are testing the bet.
Are Ozempic and similar drugs an existential threat for weight management supplements?